| Literature DB >> 27692609 |
Daniel Fernandez-Ruiz1, Wei Yi Ng2, Lauren E Holz3, Joel Z Ma1, Ali Zaid3, Yik Chun Wong4, Lei Shong Lau1, Vanessa Mollard5, Anton Cozijnsen5, Nicholas Collins1, Jessica Li2, Gayle M Davey3, Yu Kato1, Sapna Devi3, Roghieh Skandari6, Michael Pauley6, Jonathan H Manton6, Dale I Godfrey3, Asolina Braun1, Szun Szun Tay4, Peck Szee Tan7, David G Bowen4, Friedrich Koch-Nolte8, Björn Rissiek8, Francis R Carbone1, Brendan S Crabb9, Mireille Lahoud7, Ian A Cockburn10, Scott N Mueller3, Patrick Bertolino4, Geoffrey I McFadden5, Irina Caminschi11, William R Heath12.
Abstract
In recent years, various intervention strategies have reduced malaria morbidity and mortality, but further improvements probably depend upon development of a broadly protective vaccine. To better understand immune requirement for protection, we examined liver-stage immunity after vaccination with irradiated sporozoites, an effective though logistically difficult vaccine. We identified a population of memory CD8+ T cells that expressed the gene signature of tissue-resident memory T (Trm) cells and remained permanently within the liver, where they patrolled the sinusoids. Exploring the requirements for liver Trm cell induction, we showed that by combining dendritic cell-targeted priming with liver inflammation and antigen recognition on hepatocytes, high frequencies of Trm cells could be induced and these cells were essential for protection against malaria sporozoite challenge. Our study highlights the immune potential of liver Trm cells and provides approaches for their selective transfer, expansion, or depletion, which may be harnessed to control liver infections or autoimmunity.Entities:
Keywords: CD8(+) T cells; Clec9A; liver; liver surveillance; malaria; memory T cells; sporozoite; tissue-resident memory; vaccine
Mesh:
Substances:
Year: 2016 PMID: 27692609 DOI: 10.1016/j.immuni.2016.08.011
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745